Introduction
Environmental (possibly viral) and genetic factors appear to have a role in the pathogenesis of insulin dependent diabetes.' 3 Departments of Medicine We previously reported that about a quarter of insulin dependent diabetics have low plasma concentrations of the fourth component of complement (C4).45 Low C4 concentrations are found irrespective of age or duration of disease4 and are associated with diabetic microangiopathy.5 Studies of identical twins4 and families5 suggest that the characteristic of low concentrations of C4 is inherited. As C4 is important in viral neutralisation6 and the clearance of immune complexes7 it might have a role in the pathogenesis of insulin dependent diabetes and its microvascular complications.
The genes that code for C4 are on the short arm of chromosome 6 in the HLA region, this region being concerned with cellular and humoral immune responses.8 Two genes, C4A and C4B, each contribute to about half of the total serum C4 concentration. Both are highly polymorphic: 13 different variants (allotypes) have been described for the A protein and 22 for the B protein. In addition, non-expressed (null) genes have been described at each locus, which lead to lower serum concentrations of C4.9 The prevalence of null alleles is increased in insulin dependent diabetics,' 0 as are other rare C4 allotypes.1 0 11 We studied the prevalence of C4 allotypes in normal controls and in insulin dependent diabetics with and without microangiopathy.
Subjects and methods
We studied 126 white insulin dependent diabetics routinely attending two diabetic clinics in the West Midlands. Insulin dependence was defined on the basis of initial acuteness of presentation, a tendency to ketosis, requirement for insulin from diagnosis, and age at onset. Of the 126 insulin dependent diabetics, 76 had no evidence of microangiopathic complications and 50 had retinopathy with or without persistent proteinuria. Retinopathy was diagnosed by ophthalmoscopic features through dilated pupils and in most cases was confirmed by fluorescein angiography. Twenty nine subjects had severe complications (proliferative retinopathy with or without proteinuria or background retinopathy and proteinuria).
The mean (SD) age of the diabetics with complications was 36 (11) years (range 18-63) and of those without complications 28 (11) years (range 14-57). The respective durations of diabetes were 20 (9) years (range 7-35) and 12 (9) years (range 1-38).
Ninety three healthy non-diabetic white university undergraduates attending the local blood transfusion centre were studied as a control group (most were aged 18-22). None had a family history of diabetes.
Plasma C4 concentration was measured by radial immunodiffusion, and values < 0 23 g/l were defined as low, as previously described. 
Results
There was a highly significant increase in the prevalence of the null C4A (C4AQOQO) phenotype and C4B3 allotype and a reduced prevalence of the C4A3 allotype in the diabetic group compared with the controls (table I). No significant difference was seen in the prevalence of the homozygous B null phenotypes (BQOQO) between these groups.
There was a highly significant increase in the prevalence of the C4B3 allotype in the diabetics with complications compared with those without (table II) . The prevalence of the C4AQOQO phenotype was also increased in those with complications, but this did not reach significance. The patients with severe complications showed no significant increase in the prevalence of the C4B3 allotype (8/29; 280%) when compared with the group with complications as a whole (14/50; 28o ). A comparison was also made using only those patients without complications whose diabetes was of over 12 years' duration.
The groups were thus matched for duration of diabetes (group with complications (n = 50), mean (SD) 20 (9) years v group without complications (n=40), 19 (9) years). The prevalence of the C4B3 allotype was 14/50 (280o) v 3/40 (80o), respectively (p<002). All subjects with AQOQO phenotypes had low plasma C4 concentrations; and this accounted for 6000 of the subjects with low C4 concentrations reported on previously.4 
Discussion
The insulin dependent diabetics studied showed a significantly increased prevalence of the C4AQOQO phenotype and the C4B3 allotype and a reduced prevalence of the C4A3 allotype. A predictable association was also seen between the presence of the C4AQOQO phenotype and low plasma C4 concentration; this agrees with data reported elsewhere.'0 We also found a significant increase in the prevalence of the C4B3 allotype in insulin dependent diabetics with complications compared with those without. Possession of the AQOQO phenotype did not account for 400o of the low plasma C4 values reported previously. 4 Many of these subjects were probably heterozygous null for the A or B protein, or both. Phenotyping of parents and siblings, which has not yet been done would be necessary to confirm this. One other report noted a 6imilar association of allotype C4B3 with complications, although this did not achieve significance because of small numbers.'4 Much controversy remains, however, about the importance of the HLA region in the aetiology of microangiopathy.'5 It was not possible in this study to compare accurately long term metabolic control in our two groups of insulin dependent diabetics, although there was no obvious difference.
Two hypotheses, which are under evaluation, arise from our observations. Firstly, phenotypic variation of C4 in insulin dependent diabetics might be important in the aetiology of both insulin dependent diabetes and complications if it caused absolute or functional deficiency of complement, leading to defective clearance of immune complexes, viral neutralisation, or cell lysis. Supportive 
